None listed
Conditions
Brief summary
This study aims to evaluate the effect of telephone-administered CBT on outcomes for clients with diagnosed COPD who are assessed as having at least mild to moderate levels of depression and/or anxiety. It is expected that COPD patients completing telephone CBT in addition to usual pulmonary rehabilitation will have greater reductions in depression and/or anxiety scores than patients receiving usual pulmonary rehabilitation care and placebo phone contact.
Interventions
The intervention will consist of a treatment course principally consisting of telephone administered Cognitive Behavioural Therapy (CBT). Specifically it will start with a face-to-face session of 50 minutes duration at the outpatient clinic or the patient's home followed by eight scheduled weekly telephone calls of up to 30 minutes in length. The interventions include behavioural strategies such as behavioural activation, activity scheduling, relaxation training, exposure hierarchies and social skills training, as well as cognitive strategies, such as cognitive restructuring, structured problem solving and behavioural experiments. The therapist administering the telephone calls will be a registered or provisionally registered psychologist who is experienced in the delivery of telephone CBT and has knowledge of chronic obstructive pulmonary disease (COPD) education. The therapist will receive supervision by one of the Associate Researchers on the project who is a Clinical Psychologist with the relevant endorsement as a supervisor. Telephone sessions with be audio recorded to facilitate supervision. Participants will undertake assessments at screening, baseline, and two follow-up assessments (one at nine weeks and 17 weeks post commencement of intervention). Assessments will consist of administration of questionnaires. The intervention will be administered in addition to the usual care received by the participants.
Sponsors
Study design
Eligibility
Inclusion criteria
Be over 45 years of age, Have a HADS score > 8, Have a PHQ-9 score > 10, Have a diagnosis of COPD Living in the community Able to speak and understand English
Exclusion criteria
Patients who commenced anti-depressants and/or anxiolytics in the past 3 months or have had a clinically significant change in this medication in the last 3 months; Deafness.